Obermatt
See Similar Stocks →

Flags

Financial distress

Oncology Institute

NAQ:TOI · US68236X1000
Health Care Providers & ServicesSmall

360

52
Profit price80
Owner Earnings Yield1
Dividend Yield1
Price/Sales52
EV / Gross Profit32
Price/Book93
Return on Capital3
Cash Return on Capital1
EBIT Margin3
Gross Profitability99
Accruals94
Owner Earnings Margin11
Sales growth92
Profit growth13
Reinvestment18
Price momentum92
Debt load5
Refinancing57
Debt Payback1
Liquidity23
Analyst ratings87
Opinion Changes50
Price Target Upside81
Market mood4
Value Creation6/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Oncology Institute doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryHealth Care Providers & Services
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Employees336
Websitetheoncologyinstitute.com
ISINUS68236X1000
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
End-of-Life PlanningHealth DiagnosticsOutpatient CareStem Cell TherapyOncologyHealth CareHome Health Care

Description

The Oncology Institute, Inc. operates as a value-based oncology company. The company manages community-based oncology practices for the company and for independent oncology practices that together serve patients at 86 clinic locations across 16 mark…

Analysis

Middle-of-the-road

The Oncology Institute, Inc. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is solid and the balance sheet is stretched. The company scores 6/20 on our value-creation score: not creating value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
17
2023202420252026

All-time high

93

Jan 2024

All-time low

9

Jan 2025

Average rank

39

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
52
88
73
75
Price/Earnings
50
50
50
50
Price/Book
93
24
57
80
Dividend Yield
1
1
1
1
Value (overall)
50
43
54
63

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Oncology Institute with its peers
Select Medical
NYQ:SEM
41
CountryUSA
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Brightspring Health Services
NSQ:BTSG
86
CountryUSA
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
Centene
NYQ:CNC
21
CountryUSA
IndustryHealth Care Providers & Services
SizeXX-Large
Full Stock Analysis →
Community Health Systems
NYQ:CYH
23
CountryUSA
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Quipt Home Medical
TOR:QIPT
63
CountryUSA
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →
Elevance Health
NYQ:ELV
47
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →